Financial Data and Key Metrics Changes - The company reported a normalized FFO per share of $0.87, representing a year-over-year growth of approximately 9% [31] - Total company same store cash NOI grew nearly 7%, with the SHOP segment increasing over 13% [31][34] - The full year normalized FFO guidance midpoint was raised to $3.44 per share, indicating an 8% year-over-year growth at the midpoint [7][34] Business Line Data and Key Metrics Changes - The SHOP communities in the U.S. delivered 18% same store cash NOI growth in Q2, with revenue growing over 8% for the entire same store SHOP portfolio [9][16] - The outpatient medical and research business reported same store cash NOI growth of 1.7% year-over-year, led by outpatient medical, which grew NOI by 2.2% [31] - The research business, representing about 8% of NOI, experienced a decline of less than 1% year-over-year due to lower rents on certain tenants [31] Market Data and Key Metrics Changes - The average occupancy in SHOP communities improved by 240 basis points year-over-year, with the U.S. leading with a growth of 290 basis points [16][19] - The outpatient medical segment increased same store occupancy by 20 basis points sequentially and 30 basis points year-over-year to 90.1% [32] Company Strategy and Development Direction - The company is executing a "one two three" strategy aimed at driving organic growth, making value-creating investments, and maximizing performance across its portfolio [6][7] - The focus is on expanding the SHOP footprint, with expectations that SHOP NOI will represent over half of the business by year-end [13] - The company anticipates significant demand growth in senior housing due to an aging population, with the 80+ population expected to grow by 28% in the next five years [12] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's positioning to capitalize on the growing aging population and the favorable supply-demand dynamics in the senior housing market [6][14] - The management team highlighted the importance of maintaining strong relationships with operators to drive performance and growth [21][22] - The company expects to continue experiencing strong occupancy and revenue growth, particularly in the SHOP segment, supported by data analytics and operational improvements [16][19] Other Important Information - The company raised its full year 2025 senior housing investment volume guidance to $2 billion, reflecting a growing pipeline of investment opportunities [10][28] - The balance sheet showed improvement, with a net debt to EBITDA ratio of 5.6 times, indicating a 40 basis point improvement since the start of the year [32] Q&A Session Summary Question: Can you provide additional color on the sequential occupancy gain in Q2 2025? - Management noted a strong movement activity throughout the year, particularly in June, with a sequential occupancy growth of 60 basis points [39] Question: How is the competitive landscape affecting your transaction activity? - Management indicated that while competition has increased, they have been able to maintain momentum in investment activity and continue to pursue high-performing communities [42][44] Question: Can you discuss the initiatives to improve move-ins? - Management highlighted the importance of data analytics and collaboration with operators to drive sales and improve occupancy rates [48] Question: What is the historical high for outpatient medical occupancy? - The historical high for outpatient medical occupancy is around 93-94%, with current occupancy hovering around 90% [58] Question: How does the company view the impact of the new healthcare bill? - Management expects minimal immediate impact from the bill, as many changes will take effect over a long period [53][54] Question: What are the expectations for the Brookdale transition? - The transition of 45 communities from triple net to SHOP is expected to double the NOI over time, with operators already engaged in the process [90][92]

Financial Data and Key Metrics Changes - Year over year normalized FFO per share grew by 9% to $0.87, with total company same store cash NOI increasing by 7% [5][29] - Full year normalized FFO guidance midpoint raised to $3.44 per share, representing 8% year over year growth at the midpoint [5][32] - Company-wide same store cash NOI growth expectations improved to 7% at the midpoint [6][33] Business Line Data and Key Metrics Changes - SHOP communities in the US delivered 18% same store cash NOI growth in Q2, with revenue growing over 8% for the entire same store SHOP portfolio [7][14] - Outpatient medical and research business reported same store cash NOI growth of 1.7% year over year, with outpatient medical growing NOI by 2.2% [29] - Research business, representing 8% of NOI, experienced a decline of less than 1% year over year due to lower rents on certain tenants [30] Market Data and Key Metrics Changes - The 65+ population is projected to represent 20% of the US population by 2030, driving demand for outpatient medical services [10] - New construction starts in senior housing are at record lows, with only 2,000 units started in Q2, leading to supply constraints [12] Company Strategy and Development Direction - The company is executing a "one two three" strategy focused on driving organic growth in SHOP communities, making value-creating investments in senior housing, and maximizing performance in the balance of the portfolio [5][6] - The strategy includes expanding the SHOP footprint and enhancing relationships with high-performing operators to drive growth [19][20] - The company anticipates continued multiyear NOI and occupancy growth opportunities due to favorable macro conditions and supply constraints [12][13] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's positioning to capitalize on the growing aging population and the favorable supply-demand dynamics in senior housing [4][10] - The company expects to continue improving its balance sheet and leverage through organic growth and equity-funded investments [30][31] - Management highlighted the importance of data analytics and operator relationships in driving performance and occupancy growth [20][79] Other Important Information - The company has raised its full year 2025 senior housing investment volume guidance to $2 billion, reflecting increased market activity and a growing pipeline of investments [8][25] - The company reported a record level of liquidity at $4.7 billion as of June 30, bolstered by recent capital raises [31] Q&A Session Summary Question: Can you provide additional color on the sequential occupancy gain in Q2 2025? - Management noted a strong occupancy growth of 60 basis points in June versus May, with July expected to maintain or exceed this momentum [36][38] Question: How is the competitive landscape affecting your transaction activity? - Management indicated that while competition has increased, they have been able to maintain momentum in investment activity and continue to pursue high-performing communities [39][40] Question: Can you discuss the initiatives to improve move-ins? - Management highlighted the effectiveness of data analytics and collaboration with operators to drive sales and improve occupancy, particularly in independent living [45][48] Question: What is the expected impact of the new healthcare bill? - Management expects minimal immediate impact from the bill, as many provisions will take effect over a long period, but sees potential benefits for outpatient medical services [51][52] Question: What is the historical high occupancy for the outpatient medical portfolio? - The historical high occupancy is around 93-94%, with current occupancy hovering around 90% [57][58] Question: How does the occupancy growth impact RevPOR? - Management explained that higher occupancy leads to better pricing opportunities, with significant margin expansion expected as occupancy increases [66][95]

Second Quarter 2025 Performance - Normalized FFO per share was $0.87, a ~9% YoY increase, driven by SHOP NOI growth and senior housing investment activity[11] - Total Company Same-Store Cash NOI grew 6.6% YoY, led by SHOP[11] - SHOP Same-Store Cash NOI increased by 13.3% YoY, or 15% YoY excluding a $3 million property tax refund in Q2 2024[12] - U S SHOP growth was ~16%, or over 18% YoY excluding the prior year property tax refund[12] 2025 Outlook - Senior housing investment guidance increased from $1.5 billion to $2.0 billion[12] - Normalized FFO per share midpoint improved by $0.03 to $3.44[15] - SHOP Same-Store Cash NOI growth guidance range is 12% - 16%[14] Capital & Portfolio - $1.1 billion of accretive senior housing investments closed year-to-date[12, 55] - ~$1.8 billion of equity raised, including ~$0.7 billion of unsettled equity forward sales agreements[12] - Liquidity of $4.7 billion as of June 30, 2025[12] - Net Debt to Further Adjusted EBITDA improved to 5.6x, a 0.4x reduction from year-end 2024[12]

Core Insights - Ventas reported revenue of $1.42 billion for the quarter ended June 2025, marking an 18.3% increase year-over-year, with EPS at $0.87 compared to $0.05 in the same quarter last year [1] - The revenue exceeded the Zacks Consensus Estimate of $1.37 billion, resulting in a surprise of +3.47%, while the EPS also surpassed the consensus estimate of $0.85 by +2.35% [1] Revenue Breakdown - Resident fees and services generated $1.03 billion, exceeding the average estimate of $977.05 million, reflecting a year-over-year increase of +26.3% [4] - Interest and other income amounted to $5.87 million, surpassing the average estimate of $2.98 million, with a year-over-year change of +21.7% [4] - Rental income from outpatient medical & research portfolio was $220.81 million, slightly below the average estimate of $222.56 million, showing a +0.9% year-over-year change [4] - Income from loans and investments reached $4.4 million, exceeding the average estimate of $4.31 million, with a significant year-over-year increase of +206.1% [4] - Total rental income was $373.52 million, slightly below the average estimate of $376.31 million [4] - Third-party capital management revenues were $4.4 million, in line with the average estimate of $4.38 million, reflecting a +1.5% change year-over-year [4] - Rental income from triple-net leased properties was $152.7 million, slightly below the average estimate of $153.51 million, indicating a -0.8% change year-over-year [4] - Net Earnings Per Share (Diluted) was reported at $0.15, exceeding the average estimate of $0.13 [4] Stock Performance - Ventas shares have returned +6.3% over the past month, outperforming the Zacks S&P 500 composite's +3.4% change [3] - The stock currently holds a Zacks Rank 3 (Hold), suggesting it may perform in line with the broader market in the near term [3]

This quarterly report represents an FFO surprise of +2.35%. A quarter ago, it was expected that this seniors housing real estate investment trust would post FFO of $0.82 per share when it actually produced FFO of $0.84, delivering a surprise of +2.44%. Over the last four quarters, the company has surpassed consensus FFO estimates three times. Ventas, which belongs to the Zacks REIT and Equity Trust - Other industry, posted revenues of $1.42 billion for the quarter ended June 2025, surpassing the Zacks Conse ...

[Second Quarter 2025 Performance Highlights](index=1&type=section&id=Second%20Quarter%202025%20Performance%20Highlights) Ventas reported strong second-quarter 2025 results, driven by significant growth in its Senior Housing Operating Portfolio (SHOP), achieving a **9%** year-over-year increase in Normalized FFO per share to **$0.87** and a **13%** growth in SHOP Same-Store Cash NOI, leading to improved full-year guidance - CEO Debra A. Cafaro highlighted an "unprecedented multiyear growth opportunity in senior housing" driven by secular demand, historically low new supply, and an attractive product offering[3](index=3&type=chunk) Q2 2025 Key Financial Metrics (YoY) | Metric | Value | YoY Change | | :--- | :--- | :--- | | Attributable Net Income per share | $0.15 | +200% | | Normalized FFO per share | $0.87 | +9% | | Total Company Same-Store Cash NOI | N/A | +7% | | SHOP Same-Store Cash NOI | N/A | +13% | - Year to date, the company closed **$1.1 billion** in senior housing investments and settled **16.4 million shares** for gross proceeds of **$1.1 billion**, with **$0.7 billion** of unsettled equity forward sales agreements remaining[7](index=7&type=chunk) [Financial and Operating Results](index=2&type=section&id=Financial%20and%20Operating%20Results) The company's strong Q2 performance was characterized by robust growth in its Senior Housing Operating Portfolio (SHOP), with a **13%** increase in Same-Store Cash NOI, expanded senior housing investments to a **$2 billion** target, and an improved balance sheet with a reduced Net Debt-to-Adjusted EBITDA ratio of **5.6x** [Company-Level Financial Results](index=2&type=section&id=Company-Level%20Financial%20Results) Ventas demonstrated significant earnings growth in Q2 2025, with Attributable Net Income per share increasing by **200%** to **$0.15** and Normalized FFO per share growing by **9%** to **$0.87** year-over-year Q2 2025 Per Share Results vs. Q2 2024 | Metric | Q2 2025 ($/share) | Q2 2024 ($/share) | $ Change ($/share) | % Change | | :--- | :--- | :--- | :--- | :--- | | Attributable Net Income | $0.15 | $0.05 | $0.10 | 200% | | Nareit FFO* | $0.86 | $0.77 | $0.09 | 12% | | Normalized FFO* | $0.87 | $0.80 | $0.07 | 9% | [Senior Housing Operating Portfolio (SHOP) Performance](index=2&type=section&id=Senior%20Housing%20Operating%20Portfolio%20(SHOP)%20Performance) The SHOP segment was a key growth driver, with Same-Store Cash NOI increasing **13%** year-over-year, fueled by an **8%** rise in cash operating revenue, a **5%** increase in Revenue per Occupied Room, and a **240 basis point** improvement in average occupancy - SHOP Same-Store Cash NOI grew **13%** YoY, or **15%** YoY excluding a prior-year property tax refund[9](index=9&type=chunk) - Robust resident demand was observed, with accelerating average occupancy growth intra-quarter and strong net move-ins in June[10](index=10&type=chunk) [External Growth and Investment Strategy](index=2&type=section&id=External%20Growth%20and%20Investment%20Strategy) Ventas is actively pursuing external growth focused on senior housing, having closed **$1.1 billion** in investments year-to-date and increasing its full-year 2025 investment volume expectation from **$1.5 billion** to **$2.0 billion** - The company increased its 2025 investment volume expectation to **$2 billion**, up from the previous estimate of **$1.5 billion**[11](index=11&type=chunk) [Financial Position and Liquidity](index=2&type=section&id=Financial%20Position%20and%20Liquidity) The company strengthened its financial position, improving its Net Debt-to-Further Adjusted EBITDA ratio to **5.6x**, a **0.4x** reduction from year-end 2024, and maintained substantial financial flexibility with **$4.7 billion** in liquidity as of June 30, 2025 - Net Debt-to-Further Adjusted EBITDA ratio improved to **5.6x**, down **0.4x** from year-end 2024, driven by SHOP growth and equity-funded investments[12](index=12&type=chunk) - Total liquidity stood at **$4.7 billion**, including availability under its revolving credit facility, cash, and unsettled equity forward sales agreements[13](index=13&type=chunk) [Full Year 2025 Guidance](index=3&type=section&id=Full%20Year%202025%20Guidance) Ventas raised its full-year 2025 guidance, increasing the midpoint for Normalized FFO per share from **$3.41** to **$3.44**, reflecting strong SHOP segment performance and increased accretive investment activity, with the total investment target for 2025 raised to **$2.0 billion** Updated Full Year 2025 Per Share Guidance (as of 7/30/2025) | Metric | Previous Guidance (5/28/25) ($/share) | Updated Guidance (7/30/25) ($/share) | | :--- | :--- | :--- | | Attributable Net Income Range | $0.43 - $0.53 | $0.47 - $0.52 | | Nareit FFO Range* | $3.28 - $3.38 | $3.38 - $3.43 | | Normalized FFO Range* | $3.36 - $3.46 | $3.41 - $3.46 | | Normalized FFO Midpoint* | $3.41 | $3.44 | - The guidance increase is primarily driven by NOI growth in the SHOP segment and accretive senior housing investments, partially offset by higher net interest expense[16](index=16&type=chunk) - The guidance now includes the completion of **$2.0 billion** in 2025 investments, an increase from the prior assumption of **$1.5 billion**[16](index=16&type=chunk)[42](index=42&type=chunk)[45](index=45&type=chunk) [Consolidated Financial Statements](index=9&type=section&id=Consolidated%20Financial%20Statements) The consolidated financial statements detail the company's financial position and performance, showing total assets of **$26.5 billion** and total liabilities of **$14.6 billion** as of June 30, 2025, with Q2 total revenues increasing to **$1.42 billion** and net income attributable to common stockholders rising to **$68.3 million** [Consolidated Balance Sheets](index=9&type=section&id=Consolidated%20Balance%20Sheets) As of June 30, 2025, Ventas reported total assets of **$26.47 billion**, a slight increase from year-end 2024, with total liabilities decreasing to **$14.55 billion** and total equity increasing to **$11.59 billion** Balance Sheet Summary (in thousands) | Account | June 30, 2025 ($ thousands) | Dec 31, 2024 ($ thousands) | | :--- | :--- | :--- | | Total Assets | $26,474,929 | $26,186,906 | | Total Liabilities | $14,553,769 | $15,047,081 | | Total Equity | $11,592,461 | $10,829,596 | [Consolidated Statements of Income](index=10&type=section&id=Consolidated%20Statements%20of%20Income) For Q2 2025, Ventas generated total revenues of **$1.42 billion**, up from **$1.20 billion** in the prior-year period, with net income attributable to common stockholders reaching **$68.3 million**, or **$0.15** per diluted share Q2 2025 Income Statement Highlights (in thousands) | Account | Q2 2025 ($ thousands) | Q2 2024 ($ thousands) | | :--- | :--- | :--- | | Total Revenues | $1,420,893 | $1,200,980 | | Total Expenses | $1,378,235 | $1,220,064 | | Net Income | $71,462 | $21,168 | | Net Income Attributable to Common Stockholders | $68,264 | $19,387 | [Non-GAAP Financial Measures and Reconciliations](index=12&type=section&id=Non-GAAP%20Financial%20Measures%20and%20Reconciliations) This section provides detailed reconciliations of non-GAAP measures like Funds From Operations (FFO), Net Operating Income (NOI), and Adjusted EBITDA to their GAAP counterparts, offering supplemental views on the company's operating performance, property-level results, and credit strength [Funds From Operations (FFO) Reconciliation](index=12&type=section&id=Funds%20From%20Operations%20(FFO)%20Reconciliation) For Q2 2025, Ventas reconciled Net Income Attributable to Common Stockholders of **$68.3 million** to Nareit FFO of **$395.3 million** and Normalized FFO of **$400.1 million**, with Normalized FFO per share at **$0.87**, a **9%** increase year-over-year Q2 2025 FFO Reconciliation (in thousands, except per share) | Metric | Q2 2025 ($ thousands) | Q2 2024 ($ thousands) | | :--- | :--- | :--- | | Net Income Attributable to Common Stockholders | $68,264 | $19,387 | | Nareit FFO | $395,343 | $317,192 | | Normalized FFO | $400,143 | $329,119 | | Normalized FFO per share | $0.87 | $0.80 | [Full Year 2025 Guidance Reconciliation](index=14&type=section&id=Full%20Year%202025%20Guidance%20Reconciliation) The company provides a reconciliation for its updated 2025 guidance, projecting a Normalized FFO per share range of **$3.41** to **$3.46**, based on **$2.0 billion** in senior housing investments, **~$200 million** in disposition proceeds, and a full-year weighted average diluted share count of **461 million** FY 2025 Guidance Reconciliation (Per Share) | Metric | Low ($/share) | High ($/share) | | :--- | :--- | :--- | | Net income attributable to common stockholders | $0.47 | $0.52 | | Nareit FFO attributable to common stockholders | $3.38 | $3.43 | | Normalized FFO attributable to common stockholders | $3.41 | $3.46 | - Updated guidance assumptions include increased senior housing investment volume to **$2.0 billion** and a slightly higher weighted average share count of **461 million**[42](index=42&type=chunk) [Same-Store Cash NOI Reconciliation](index=16&type=section&id=Same-Store%20Cash%20NOI%20Reconciliation) In Q2 2025, Total Same-Store Cash NOI was **$485.3 million**, a **6.6%** increase year-over-year, led by the SHOP segment's **13.3%** increase to **$226.1 million**, with OM&R and NNN segments growing by **1.7%** and **1.0%** respectively Q2 2025 Same-Store Cash NOI Growth by Segment (YoY) | Segment | Q2 2025 Same-Store Cash NOI ($ thousands) | % Increase | | :--- | :--- | :--- | | SHOP | $226,068 | 13.3% | | OM&R | $135,912 | 1.7% | | NNN | $123,368 | 1.0% | | **Total** | **$485,348** | **6.6%** | [Adjusted EBITDA and Net Debt Reconciliation](index=18&type=section&id=Adjusted%20EBITDA%20and%20Net%20Debt%20Reconciliation) The company's Net Debt to Further Adjusted EBITDA ratio improved sequentially and from year-end 2024, standing at **5.6x** for Q2 2025, compared to **5.7x** in the prior quarter and **6.0x** at year-end 2024, indicating a strengthening credit profile Net Debt / Further Adjusted EBITDA Trend | Quarter Ended | Ratio (x) | | :--- | :--- | | June 30, 2025 | 5.6x | | March 31, 2025 | 5.7x | | December 31, 2024 | 6.0x | [Definitions of Non-GAAP Measures](index=19&type=section&id=Definitions%20of%20Non-GAAP%20Measures) This section provides the company's specific definitions for key non-GAAP financial measures such as Adjusted EBITDA, Further Adjusted EBITDA, NOI, Cash NOI, Same-Store, and Constant Currency, crucial for understanding supplemental performance metrics - The company defines NOI as total revenues less property-level operating expenses, third-party capital management expenses, and interest and other income[53](index=53&type=chunk) - Same-store properties are defined as those owned, consolidated, and operational for the full period in both comparison periods, with specific stabilization criteria for newly developed or acquired assets[55](index=55&type=chunk)[56](index=56&type=chunk) [About Ventas and Forward-Looking Statements](index=3&type=section&id=About%20Ventas%20and%20Forward-Looking%20Statements) Ventas is an S&P 500 REIT with approximately **1,400 properties** focused on senior housing, medical buildings, and research centers, with the report including cautionary statements on forward-looking information and outlining risk factors like regulatory changes and macroeconomic conditions - Ventas is a leading S&P 500 REIT with a portfolio of approximately **1,400 properties** in North America and the United Kingdom, focusing on the senior housing and healthcare sectors[20](index=20&type=chunk) - The press release contains forward-looking statements subject to various risks and uncertainties, and the company does not undertake a duty to update them[25](index=25&type=chunk)[26](index=26&type=chunk) - Key risk factors include exposure to governmental regulations, macroeconomic conditions like inflation and interest rates, reliance on third-party managers, and the financial condition of tenants and borrowers[27](index=27&type=chunk)[28](index=28&type=chunk)

Core Insights - Wall Street analysts expect Ventas (VTR) to report quarterly earnings of $0.85 per share, reflecting a year-over-year increase of 6.3% [1] - Revenues are projected to be $1.37 billion, which represents a 14.3% increase from the same quarter last year [1] - The consensus EPS estimate has been revised upward by 0.7% over the past 30 days, indicating a collective reassessment by analysts [1] Revenue Estimates - Analysts estimate 'Revenues- Rental income- Outpatient medical & research portfolio' to be $222.56 million, showing a 1.7% increase from the prior year [4] - 'Revenues- Interest and other income' is expected to be $2.98 million, indicating a significant decrease of 38.2% from the previous year [4] - 'Revenues- Resident fees and services' are projected to reach $977.05 million, reflecting a 19.5% increase year-over-year [5] - 'Revenues- Rental income- Triple-net leased' is estimated at $153.51 million, showing a slight decrease of 0.3% from the year-ago quarter [5] - 'Revenues- Third party capital management revenues' are expected to be $4.38 million, indicating a 1.1% increase from the prior year [6] Other Financial Metrics - Depreciation and amortization is projected to reach $319.33 million [6] - Ventas shares have increased by 3.3% over the past month, compared to a 3.6% increase in the Zacks S&P 500 composite [6] - The company holds a Zacks Rank 3 (Hold), suggesting it is expected to closely follow overall market performance in the near term [6]

Core Insights - Ventas (VTR) shares have increased by 11.6% over the past six months, outperforming the industry growth of 6% [1][8] - The company is positioned to benefit from its diverse healthcare real estate portfolio, particularly in the U.S. and U.K., driven by an aging population and increased healthcare spending by seniors [1][4] Company Performance - The senior housing operating portfolio (SHOP) is expected to see significant growth, with same-store cash NOI projected to increase between 11% and 16% by 2025 [4] - The outpatient medical portfolio is anticipated to benefit from favorable trends in outpatient visits, with the population aged 65 and above making three times more visits to doctors than the general population [5] Growth Opportunities - Ventas is making accretive investments to enhance its research portfolio, which is crucial for healthcare services and life-saving research [6] - The company has a liquidity position of $3.6 billion, bolstered by an expanded unsecured credit facility, which supports its growth initiatives [9] Market Trends - The increasing senior citizen population and low new supply in Ventas' markets present a compelling multiyear growth opportunity for the company [4] - The company expects its outpatient medical and research (OM&R) portfolio's same-store cash NOI to grow by 2-3% in 2025 [5]

Group 1 - Ventas, Inc. (NYSE: VTR) is a real estate investment trust (REIT) focused on the health care sector within the real estate industry [1] - The company is positioned to benefit from the aging population and increasing demand for health care facilities [1] - The investment thesis is bullish, indicating a positive outlook for the company's financial performance and stock price appreciation [1] Group 2 - The article emphasizes the importance of having both long-term and short-term trading strategies for individual investors [1] - The author aims to develop winning trades and improve investment results through focused analysis and feedback [1]

Group 1: Zacks Premium and Style Scores Overview - Zacks Premium offers various tools for investors to enhance their stock market strategies, including daily updates on Zacks Rank and Industry Rank, Equity Research reports, and Premium stock screens [1] - The Zacks Style Scores rate stocks based on value, growth, and momentum characteristics, serving as complementary indicators to the Zacks Rank [2][3] Group 2: Style Scores Categories - The Value Score focuses on identifying undervalued stocks using ratios like P/E, PEG, and Price/Sales to highlight attractive investment opportunities [3] - The Growth Score emphasizes a company's financial strength and future outlook, analyzing projected and historical earnings, sales, and cash flow for sustainable growth [4] - The Momentum Score helps investors capitalize on price trends by assessing one-week price changes and monthly earnings estimate changes [5] - The VGM Score combines all three Style Scores, providing a comprehensive indicator for evaluating stocks based on value, growth, and momentum [6] Group 3: Zacks Rank and Performance - The Zacks Rank is a proprietary model that utilizes earnings estimate revisions to assist investors in building successful portfolios [7] - Stocks rated 1 (Strong Buy) have achieved an average annual return of +25.41% since 1988, significantly outperforming the S&P 500 [8] - Investors are encouraged to select stocks with a Zacks Rank of 1 or 2 and Style Scores of A or B to maximize returns [9] Group 4: Stock Highlight - Ventas, Inc. - Ventas, Inc. is a healthcare REIT with investments in 1,406 properties across North America and the U.K. as of March 31, 2025 [11] - Currently rated 3 (Hold) with a VGM Score of B, Ventas has a Momentum Style Score of A, and its shares have increased by 0.6% over the past four weeks [12] - The Zacks Consensus Estimate for Ventas' earnings has risen by $0.02 to $3.45 per share, with an average earnings surprise of 1.2% [12]